+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Tegretol"

Global Anti-Epileptic Drugs Market: Analysis By Drug Generation, By Distribution Channel, By Region Size and Trends with Impact of COVID-19 and Forecast up to 2028 - Product Thumbnail Image

Global Anti-Epileptic Drugs Market: Analysis By Drug Generation, By Distribution Channel, By Region Size and Trends with Impact of COVID-19 and Forecast up to 2028

  • Report
  • October 2023
  • 159 Pages
  • Global
From
CNS Therapeutics - Global Strategic Business Report - Product Thumbnail Image

CNS Therapeutics - Global Strategic Business Report

  • Report
  • April 2024
  • 898 Pages
  • Global
From
  • 2 Results (Page 1 of 1)
Loading Indicator

Tegretol is a brand name of the anticonvulsant drug carbamazepine, which is used to treat epilepsy, trigeminal neuralgia, and bipolar disorder. It is a member of the Central Nervous System (CNS) drug class, which includes drugs used to treat neurological disorders. Tegretol is a first-line treatment for epilepsy, and is also used to treat bipolar disorder and trigeminal neuralgia. It is available in both immediate-release and extended-release formulations. Tegretol is marketed by Novartis, a Swiss multinational pharmaceutical company. Other companies that market CNS drugs include Pfizer, GlaxoSmithKline, Johnson & Johnson, and Eli Lilly. Show Less Read more